Conforti, F., Bagnardi, V., Sala, I. (2025). Reply to: “Inappropriate Conclusions on Surrogate End Points in Early Breast Cancer Trials” and “Methodologic Considerations in Assessing Invasive Disease-Free Survival as a Surrogate End Point for Overall Survival in Trials for Early Breast Cancer”. Journal of Clinical Oncology. https://doi.org/10.1200/jco-25-01041